跳至主要内容
临床试验/IRCT20210201050199N1
IRCT20210201050199N1尚未招募3 期

Therapeutic effect of oral ursodeoxycholic acid on indirect hyperbilirubinemia in full-term neonates undergoing phototherapy in hospital 17 Shahrivar - a randomized controlled clinical trial

Rasht University of Medical Sciences0 个研究点目标入组 106 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
3 days 至 7 days(—)
性别
All

入选标准

  • Parents' complete satisfaction with the presence of children in the study
  • Birth weight 2500 to 4000 grams
  • Exclusive breastfeeding,
  • Gestational age 38 to 41 weeks
  • Age 3 to 7 days
  • Total bilirubin 14 to 20 and direct bilirubin less than 2

排除标准

  • ABO and RH incompatibility
  • G6PD enzyme deficiency
  • Direct hyperbilirubinemia
  • Diseases leading to hyperbilirubinemia (carpenter Kriegler syndrome, Gilbert syndrome, hyperthyroidism, hypothyroidism, liver disease)
  • Neonate of mothers with gestational diabetes mellitus

研究者

发起方
Rasht University of Medical Sciences

相似试验